409 related articles for article (PubMed ID: 18688211)
1. Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain.
Chernoloz O; El Mansari M; Blier P
Neuropsychopharmacology; 2009 Feb; 34(3):651-61. PubMed ID: 18688211
[TBL] [Abstract][Full Text] [Related]
2. Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain.
Chernoloz O; El Mansari M; Blier P
J Psychiatry Neurosci; 2012 Feb; 37(2):113-21. PubMed ID: 22023785
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain.
Ghanbari R; El Mansari M; Blier P
Eur Neuropsychopharmacol; 2012 Jul; 22(7):518-26. PubMed ID: 22154666
[TBL] [Abstract][Full Text] [Related]
4. Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.
El Mansari M; Ghanbari R; Janssen S; Blier P
Neuropharmacology; 2008 Dec; 55(7):1191-8. PubMed ID: 18708076
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder.
Chernoloz O; El Mansari M; Blier P
Psychopharmacology (Berl); 2009 Oct; 206(2):335-44. PubMed ID: 19641901
[TBL] [Abstract][Full Text] [Related]
6. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons.
Katz NS; Guiard BP; El Mansari M; Blier P
J Psychopharmacol; 2010 Aug; 24(8):1223-35. PubMed ID: 19939862
[TBL] [Abstract][Full Text] [Related]
8. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
[TBL] [Abstract][Full Text] [Related]
9. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission.
Dorr AE; Debonnel G
J Pharmacol Exp Ther; 2006 Aug; 318(2):890-8. PubMed ID: 16690723
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus.
Haddjeri N; Lavoie N; Blier P
Neuropsychopharmacology; 2004 Oct; 29(10):1800-6. PubMed ID: 15127086
[TBL] [Abstract][Full Text] [Related]
11. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT
De Gregorio D; Posa L; Ochoa-Sanchez R; McLaughlin R; Maione S; Comai S; Gobbi G
Pharmacol Res; 2016 Nov; 113(Pt A):81-91. PubMed ID: 27544651
[TBL] [Abstract][Full Text] [Related]
12. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions.
Guiard BP; El Mansari M; Merali Z; Blier P
Int J Neuropsychopharmacol; 2008 Aug; 11(5):625-39. PubMed ID: 18205979
[TBL] [Abstract][Full Text] [Related]
13. Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment.
Dong J; Blier P
Psychopharmacology (Berl); 2001 Apr; 155(1):52-7. PubMed ID: 11374336
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological effects of the co-administration of escitalopram and bupropion on rat serotonin and norepinephrine neurons.
Ghanbari R; El Mansari M; Blier P
J Psychopharmacol; 2010 Jan; 24(1):39-50. PubMed ID: 18719044
[TBL] [Abstract][Full Text] [Related]
15. Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neurons.
Szabo ST; Blier P
J Pharmacol Exp Ther; 2002 Sep; 302(3):983-91. PubMed ID: 12183655
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of pardoprunox (SLV308), a partial D₂/D₃ receptor and 5-HT1A receptor agonist, on rat dopamine and serotonin neuronal activity.
Bétry C; Etiévant A; Lambás-Señas L; McCreary AC; Haddjeri N
Synapse; 2011 Oct; 65(10):1042-51. PubMed ID: 21446003
[TBL] [Abstract][Full Text] [Related]
17. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
18. Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus.
Szabo ST; Blier P
Synapse; 2001 Dec; 42(4):203-12. PubMed ID: 11746719
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073
[TBL] [Abstract][Full Text] [Related]
20. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.
Claustre Y; Peretti DD; Brun P; Gueudet C; Allouard N; Alonso R; Lourdelet J; Oblin A; Damoiseau G; Françon D; Suaud-Chagny MF; Steinberg R; Sevrin M; Schoemaker H; George P; Soubrié P; Scatton B
Neuropsychopharmacology; 2003 Dec; 28(12):2064-76. PubMed ID: 12902994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
